SEC Form 4 · accession 0001209191-15-065006
Tracon Pharmaceuticals, Inc. · TCON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Period of report
Aug 7, 2015
Accepted (ET)
Aug 10, 2015 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001394319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2015 | S | 2,300 | $11.83 | D | 1,557,420 | D | |
| Common Stock | Aug 10, 2015 | S | 6,000 | $11.50 | D | 1,551,420 | D |
Table II — derivative securities
No Table II lines on this filing.